Physician profile
Sameh E Mikhail
NPI 1447455720
$134,974.79
in general payments reported to CMS, 2019-2025
81 companies · $44K in 2025
The $44K reported for 2025 was more than what 96% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $5,612 · 2021: $16K · 2022: $31K · 2023: $5,843 · 2024: $18K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Consulting Fee: $21K · Food and Beverage: $7,747 · Travel and Lodging: $4,739 · Education: $54.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,758.00 |
| Consulting Fee | $21,062.25 |
| Food and Beverage | $7,747.20 |
| Travel and Lodging | $4,739.20 |
| Education | $54.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $36,784.83 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $35,408.85 | 2019-2025 | Onivyde, Tazverik |
| Emd Serono, INC. | $7,601.74 | 2019-2025 | Tepmetko, Bavencio |
| Bayer Healthcare Pharmaceuticals INC. | $7,255.50 | 2019-2025 | |
| Deciphera Pharmaceuticals INC. | $6,289.65 | 2020-2025 | Qinlock |
| Rigel Pharmaceuticals, INC. | $5,411.25 | 2019-2024 | Rezlidhia, Tavalisse |
| Astrazeneca Pharmaceuticals LP | $4,850.59 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Seagen INC. | $4,738.59 | 2019-2023 | Padcev, Adcetris, Tukysa |
| Janssen Biotech, INC. | $3,628.78 | 2019-2025 | Rybrevant, Darzalex, Erleada |
| Taiho Oncology, INC. | $3,543.54 | 2020-2025 | |
| Daiichi Sankyo INC. | $3,051.99 | 2019-2025 | Enhertu, Datroway |
| Beigene USA, INC. | $2,440.53 | 2020-2024 | Tevimbra |
| Btg International INC. | $1,500.00 | 2024 | |
| Cti Biopharma Corp. | $1,475.83 | 2022 | |
| Epizyme, INC. | $1,316.55 | 2021 |
Show all 81 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geron Corporation | $1,266.58 | 2025 | Rytelo |
| Caris Mpi, INC. | $1,063.03 | 2025 | Mi Cancer Seek |
| Eisai INC. | $684.26 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $508.85 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $420.78 | 2019-2024 | Fruzaqla, Alunbrig, Ninlaro |
| Novartis Pharmaceuticals Corporation | $360.31 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $312.20 | 2019-2025 | Opdivo, Opdualag |
| Pfizer INC. | $300.76 | 2023-2025 | |
| Karyopharm Therapeutics INC. | $244.10 | 2020-2024 | Xpovio |
| Array Biopharma INC | $230.51 | 2021-2025 | Mektovi, Braftovi, Lorbrena |
| Exelixis INC. | $230.23 | 2019-2025 | Cabometyx |
| Celgene Corporation | $229.40 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Incyte Corporation | $226.32 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Novocure Gmbh | $200.00 | 2022 | |
| Genzyme Corporation | $187.30 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $185.82 | 2023-2025 | Fotivda |
| Genentech USA, INC. | $177.64 | 2021-2024 | Venclexta, Alecensa, Tecentriq |
| Adaptive Biotechnologies Corporation | $166.15 | 2024-2025 | Clonoseq |
| Abbvie INC. | $144.77 | 2019-2025 | |
| Sirtex Medical INC | $142.41 | 2022 | |
| Springworks Therapeutics, INC. | $133.16 | 2024-2025 | Ogsiveo, Gomekli |
| Janssen Scientific Affairs, LLC | $130.78 | 2024 | Darzalex, Talvey, Tecvayli |
| Regeneron Healthcare Solutions, INC. | $125.36 | 2023-2025 | Libtayo |
| Glaxosmithkline, LLC. | $117.31 | 2020-2025 | Ojjaara |
| Coherus Oncology, INC. | $114.52 | 2021-2025 | Loqtorzi |
| Lilly USA, LLC | $113.35 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Gilead Sciences, INC. | $100.44 | 2022-2025 | Trodelvy |
| Amgen INC. | $99.86 | 2019-2021 | |
| Astellas Pharma US INC | $89.56 | 2023-2025 | Padcev, Xospata, Vyloy |
| Blueprint Medicines Corporation | $85.67 | 2020-2025 | Ayvakit |
| Pharmacyclics LLC, An Abbvie Company | $84.43 | 2021-2023 | Epkinly, Imbruvica |
| Sobi, INC | $84.38 | 2024-2025 | |
| Adc Therapeutics America, INC. | $72.41 | 2022-2024 | |
| Amag Pharmaceuticals, INC. | $69.11 | 2021-2022 | |
| Stemline Therapeutics INC. | $56.92 | 2023-2025 | Orserdu |
| Mirati Therapeutics, INC. | $56.34 | 2023 | Krazati |
| Pharmacosmos Therapeutics INC. | $51.19 | 2023-2024 | Monoferric, Cosela |
| Tersera Therapeutics LLC | $48.42 | 2023-2025 | Zoladex, Xermelo |
| Kite Pharma, INC. | $48.17 | 2022-2024 | Yescarta |
| Acceleron Pharma, INC. | $46.80 | 2020-2021 | |
| Foundation Medicine, INC. | $45.72 | 2020-2023 | |
| Progenics Pharmaceuticals, INC. | $44.79 | 2025 | |
| Servier Pharmaceuticals LLC | $43.46 | 2024 | |
| Accord Healthcare, INC. | $43.42 | 2025 | |
| Alexion Pharmaceuticals, INC. | $40.95 | 2019-2023 | Ultomiris |
| Acrotech Biopharma INC. | $39.35 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $36.73 | 2020 | |
| Genmab U.S., INC. | $36.46 | 2024 | Epkinly |
| Sumitomo Pharma America, INC. | $31.01 | 2023-2024 | Orgovyx |
| Legend Biotech USA INC. | $30.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.41 | 2019-2023 | Gilotrif |
| Organon LLC | $27.74 | 2025 | |
| Octapharma USA, INC. | $24.74 | 2025 | Octagam Immune Globulin (Human) |
| Tempus Ai, INC | $19.51 | 2025 | Xt Cdx |
| Amneal Pharmaceuticals LLC | $18.29 | 2023 | Neulasta, Avastin, Neupogen |
| Agios Pharmaceuticals, INC. | $17.50 | 2024 | Pyrukynd |
| Fennec Pharmaceuticals, INC. | $16.76 | 2024 | Pedmark |
| Pharmaessentia USA Corporation | $15.99 | 2022 | |
| Immunogen, INC. | $15.20 | 2023 | Elahere |
| Secura Bio, INC. | $14.80 | 2020 | |
| Iovance Biotherapeutics, INC. | $14.68 | 2025 | Amtagvi |
| Janssen Pharmaceuticals, INC | $12.62 | 2023 | Xarelto |
| Heron Therapeutics, INC. | $12.57 | 2021 | |
| Dova Pharmaceuticals | $12.52 | 2021 | |
| Aurobindo Pharma USA, INC. | $12.35 | 2019 | |
| Clovis Oncology, INC. | $9.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.